Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1980 Aug;64(8):576–590. doi: 10.1136/bjo.64.8.576

Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.

M S Sunba, A H Rahi, G Morgan, E J Holborow
PMCID: PMC1043764  PMID: 7426575

Full text

PDF
576

Images in this article

583Image
on p.583
583Image
on p.583
587Image
on p.587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON B., O'NEILL J. Malignant melanoma of the uvea; observations on growth and behavior, enucleation refused or delayed. AMA Arch Ophthalmol. 1957 Sep;58(3):337–347. [PubMed] [Google Scholar]
  2. ASHTON N. PRIMARY TUMOURS OF THE IRIS. Br J Ophthalmol. 1964 Dec;48:650–668. doi: 10.1136/bjo.48.12.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Broder S., Waldmann T. A. The suppressor-cell network in cancer (first of two parts). N Engl J Med. 1978 Dec 7;299(23):1281–1284. doi: 10.1056/NEJM197812072992305. [DOI] [PubMed] [Google Scholar]
  4. Broder S., Waldmann T. A. The suppressor-cell network in cancer (second of two parts). N Engl J Med. 1978 Dec 14;299(24):1335–1341. doi: 10.1056/NEJM197812142992404. [DOI] [PubMed] [Google Scholar]
  5. Carpentier N. A., Lange G. T., Fiere D. M., Fournie G. J., Lambert P. H., Miescher P. A. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis. J Clin Invest. 1977 Oct;60(4):874–884. doi: 10.1172/JCI108842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Char D. H., Christensen M., Goldberg L., Stein P. Immune complexes in retinoblastoma. Am J Ophthalmol. 1978 Sep;86(3):395–399. doi: 10.1016/0002-9394(78)90245-3. [DOI] [PubMed] [Google Scholar]
  7. Char D. H., Hollinshead A., Cogan D. G., Ballintine E. J., Hogan M. J., Herberman R. B. Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma. N Engl J Med. 1974 Aug 8;291(6):274–277. doi: 10.1056/NEJM197408082910603. [DOI] [PubMed] [Google Scholar]
  8. Colvin R. B., Dvorak H. F. Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions. J Immunol. 1975 Jan;114(1 Pt 2):377–387. [PubMed] [Google Scholar]
  9. Cooperband S. R., Nimberg R., Schmid K., Mannick J. A. Humoral immunosuppressive factors. Transplant Proc. 1976 Jun;8(2):225–242. [PubMed] [Google Scholar]
  10. Crozier E. H., Hollinger M. E., Woodend B. E., Robertson J. H. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis. J Clin Pathol. 1976 Jul;29(7):608–609. doi: 10.1136/jcp.29.7.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DUNPHY E. B., FORREST A. W., LEOPOLD I. H., REESE A. B., ZIMMERMAN L. E. The diagnosis and management of intraocular melanomas: a symposium. Trans Am Acad Ophthalmol Otolaryngol. 1958 Jul-Aug;62(4):517–555. [PubMed] [Google Scholar]
  12. Dernouchamps J. P., Vaerman J. P., Michiels J., Masson P. L. Immune complexes in the aqueous humor and serum. Am J Ophthalmol. 1977 Jul;84(1):24–31. doi: 10.1016/0002-9394(77)90319-1. [DOI] [PubMed] [Google Scholar]
  13. Dobersen M. J., Bell A. M., Jenson A. B., Notkins A. L., Ginsberg-Fellner F. Detection of antibodies to islet cells and insulin with paraffin-embedded pancreas as antigen. Lancet. 1979 Nov 17;2(8151):1078–1078. doi: 10.1016/s0140-6736(79)92477-2. [DOI] [PubMed] [Google Scholar]
  14. Elhilali M. M., Paika K. D., Brosman S., Fahey J. L. Critical evaluation of lymphocyte functions in urological cancer patients. Cancer Res. 1976 Jan;36(1):132–137. [PubMed] [Google Scholar]
  15. FERRY A. P. LESIONS MISTAKEN FOR MALIGNANT MELANOMA OF THE POSTERIOR UVEA. A CLINICOPATHOLOGIC ANALYSIS OF 100 CASES WITH OPHTHALMOSCOPICALLY VISIBLE LESIONS. Arch Ophthalmol. 1964 Oct;72:463–469. doi: 10.1001/archopht.1964.00970020463004. [DOI] [PubMed] [Google Scholar]
  16. FURTH J. Conditioned and autonomous neoplasms: a review. Cancer Res. 1953 Jul;13(71):477–492. [PubMed] [Google Scholar]
  17. Federman J. L., Lewis M. G., Clark W. H. Tumor-associated antibodies to ocular and cutaneous malignant melanomas: negative interaction with normal choroidal melanocytes. J Natl Cancer Inst. 1974 Feb;52(2):587–589. doi: 10.1093/jnci/52.2.587. [DOI] [PubMed] [Google Scholar]
  18. Fidler I. J., Cifone M. A. Properties of metastatic and nonmetastatic cloned subpopulations of an ultraviolet-light-induced murine fibrosarcoma of recent origin. Am J Pathol. 1979 Dec;97(3):633–648. [PMC free article] [PubMed] [Google Scholar]
  19. Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
  20. Gass J. D. Problems in the differential diagnosis of choroidal nevi and malignant melanomas. The XXXIII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1977 Mar;83(3):299–323. doi: 10.1089/ten.2005.11.1254. [DOI] [PubMed] [Google Scholar]
  21. Goldstone A. H., Kerr L., Irvine W. J. The macrophage electrophoretic migration test in cancer. Clin Exp Immunol. 1973 Jul;14(3):469–472. [PMC free article] [PubMed] [Google Scholar]
  22. Golub S. H., Morton D. L. Sensitisation of lymphocytes in vitro against human melanoma-associated antigens. Nature. 1974 Sep 13;251(5471):161–163. doi: 10.1038/251161a0. [DOI] [PubMed] [Google Scholar]
  23. Grierson I., Lee W. R. Erythrocyte phagocytosis in the human trabecular meshwork. Br J Ophthalmol. 1973 Jun;57(6):400–415. doi: 10.1136/bjo.57.6.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hamlin I. M. Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer. 1968 Sep;22(3):383–401. doi: 10.1038/bjc.1968.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Harry J. Symposium on management of melanoma of the uveal tract. Errors in diagnosis. Trans Ophthalmol Soc U K. 1973;93(0):93–102. [PubMed] [Google Scholar]
  26. Houck J. C., Sharma V. K., Cheng R. F. Fibroblast chalone and serum mitogen (anti-chalone). Nat New Biol. 1973 Nov 28;246(152):111–113. doi: 10.1038/newbio246111a0. [DOI] [PubMed] [Google Scholar]
  27. Jehn U. W., Nathanson L., Schwartz R. S., Skinner M. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma. N Engl J Med. 1970 Aug 13;283(7):329–333. doi: 10.1056/NEJM197008132830702. [DOI] [PubMed] [Google Scholar]
  28. Jensen O. A., Andersen S. R. Spontaneous regression of a malignant melanoma of the choroid. Acta Ophthalmol (Copenh) 1974;52(2):173–182. doi: 10.1111/j.1755-3768.1974.tb00365.x. [DOI] [PubMed] [Google Scholar]
  29. Kerbel R. S. Immunologic studies of membrane mutants of a highly metastatic murine tumor. Am J Pathol. 1979 Dec;97(3):609–622. [PMC free article] [PubMed] [Google Scholar]
  30. Kåresen R. The immune reaction against malignant melanoma studied in a biopsy material. Acta Pathol Microbiol Scand A. 1974 Jan;82(1):116–126. doi: 10.1111/j.1699-0463.1974.tb03833.x. [DOI] [PubMed] [Google Scholar]
  31. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  32. Lewkonia R. M., Kerr E. J., Irvine W. J. Clinical evaluation of the macrophage electrophoretic mobility test for cancer. Br J Cancer. 1974 Dec;30(6):532–537. doi: 10.1038/bjc.1974.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Manor R. S., Livni E., Joshua H., Ben-Sira I. Inhibition of macrophage migration by choroidal malignant melanoma-associated antigens in patients with unveal melanoma. Invest Ophthalmol Vis Sci. 1978 Jul;17(7):684–687. [PubMed] [Google Scholar]
  34. Meltzer M. S., Leonard E. J., Rapp H. J., Borsos T. Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst. 1971 Sep;47(3):703–709. [PubMed] [Google Scholar]
  35. Muir V. Y., Turk J. L., Hanley H. G. Comparison of allergic aspermatogenesis with that induced by vasectomy. I. In vivo studies in the guinea-pig. Clin Exp Immunol. 1976 Apr;24(1):72–80. [PMC free article] [PubMed] [Google Scholar]
  36. NEWTON F. H. MALIGNANT MELANOMA OF CHOROID. REPORT OF A CASE WITH CLINICAL HISTORY OF 36 YEARS AND FOLLOW UP OF 32 YEARS. Arch Ophthalmol. 1965 Feb;73:198–199. doi: 10.1001/archopht.1965.00970030200009. [DOI] [PubMed] [Google Scholar]
  37. Nagel G. A., Piessens W. F., Stilmant M. M., Lejeune F. Evidence for tumor-specific immunity in human malignant melanoma. Eur J Cancer. 1971 Feb;7(1):41–47. doi: 10.1016/0014-2964(71)90093-4. [DOI] [PubMed] [Google Scholar]
  38. Oettgen H. F. Immunotherapy of cancer. N Engl J Med. 1977 Sep 1;297(9):484–491. doi: 10.1056/NEJM197709012970907. [DOI] [PubMed] [Google Scholar]
  39. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer. 1973 Jan;27(1):1–9. doi: 10.1038/bjc.1973.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rahi A. H., Agrawal P. K. Prognsotic parameters in choroidal melanomata. Trans Ophthalmol Soc U K. 1977 Sep;97(3):368–372. [PubMed] [Google Scholar]
  41. Rahi A. H. Autoimmune reactions in uveal melanoma. Br J Ophthalmol. 1971 Dec;55(12):793–807. doi: 10.1136/bjo.55.12.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rahi A. H., Garner A., Malaty A. H. Contractile protein antigens in the cells of malignant melanoma of the choroid and their diagnostic significance. Br J Ophthalmol. 1978 Jun;62(6):394–401. doi: 10.1136/bjo.62.6.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rahi A. H. Immunological aspects of malignant melanoma of the choroid. Trans Ophthalmol Soc U K. 1973;93(0):79–91. [PubMed] [Google Scholar]
  44. Rahi A. H., Otiko G., Winder A. F. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours. Br J Ophthalmol. 1976 Aug;60(8):589–593. doi: 10.1136/bjo.60.8.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Reese A. B., Archila E. A., Jones I. S., Cooper W. C. Necrosis of malignant melanoma of the choroid. Am J Ophthalmol. 1970 Jan;69(1):91–104. doi: 10.1016/0002-9394(70)91860-x. [DOI] [PubMed] [Google Scholar]
  46. Robinson A. G., Loeb J. N. Ethanol ingestion--commonest cause of elevated plasma osmolality? N Engl J Med. 1971 Jun 3;284(22):1253–1255. doi: 10.1056/NEJM197106032842209. [DOI] [PubMed] [Google Scholar]
  47. Roubin R., Césarini J. P., Fridman W. H., Pavie-Fischer J., Peter H. H. Characterization of the mononuclear cell infiltrate in human malignant melanoma. Int J Cancer. 1975 Jul 15;16(1):61–73. doi: 10.1002/ijc.2910160108. [DOI] [PubMed] [Google Scholar]
  48. Schumm D. E., Billmire D. F., Morris H. P. Inhibition of mitogen-induced lymphocyte blastogenesis by serum from tumor-bearing animals: changes with tumor growth. Eur J Cancer. 1976 Sep;12(9):689–694. doi: 10.1016/0014-2964(76)90017-7. [DOI] [PubMed] [Google Scholar]
  49. Sell S. Tumor immunity: relevance of animal models to man. Hum Pathol. 1978 Jan;9(1):63–69. doi: 10.1016/s0046-8177(78)80008-2. [DOI] [PubMed] [Google Scholar]
  50. Shields J. A. Lesions simulating malignant melanoma of the posterior uvea. Arch Ophthalmol. 1973 Jun;89(6):466–471. doi: 10.1001/archopht.1973.01000040468004. [DOI] [PubMed] [Google Scholar]
  51. Sunba M. S., Rahi A. H., Morgan G. Tumors of the anterior uvea. I. Metastasizing malignant melanoma of the iris. Arch Ophthalmol. 1980 Jan;98(1):82–85. doi: 10.1001/archopht.1980.01020030084004. [DOI] [PubMed] [Google Scholar]
  52. Tritsch H. Untersuchungen über Relationen zwischen entzündlicher Infiltration, Zelltyp und Prognose beim malignen Melanom. Arch Dermatol Forsch. 1972;244:222–223. [PubMed] [Google Scholar]
  53. Vánky F., Stjernswärd J., Nilsonne U. Cellular immunity to human sarcoma. J Natl Cancer Inst. 1971 Jun;46(6):1145–1151. [PubMed] [Google Scholar]
  54. Weiss L. Dynamic aspects of cancer cell populations in metastasis. Am J Pathol. 1979 Dec;97(3):601–608. [PMC free article] [PubMed] [Google Scholar]
  55. Whittaker M. G., Rees K., Clark C. G. Reduced lymphocyte transformation in breast cancer. Lancet. 1971 May 1;1(7705):892–893. doi: 10.1016/s0140-6736(71)92448-2. [DOI] [PubMed] [Google Scholar]
  56. Wong I. G., Oskvig R. M. Immunofluorescent detection of antibodies to ocular melanomas. Arch Ophthalmol. 1974 Aug;92(2):98–102. doi: 10.1001/archopht.1974.01010010104004. [DOI] [PubMed] [Google Scholar]
  57. Zembala M., Mytar B., Popiela T., Asherson G. L. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer. 1977 May 15;19(5):605–613. doi: 10.1002/ijc.2910190503. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES